Literature DB >> 16442671

Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys.

Wayne A Cass1, Richard Grondin, Anders H Andersen, Zhiming Zhang, Peter A Hardy, Lindsay K Hussey-Andersen, William S Rayens, Greg A Gerhardt, Don M Gash.   

Abstract

Changes in the nigrostriatal system may be involved with the motor abnormalities seen in aging. These perturbations include alterations in dopamine (DA) release, regulation and transport in the striatum and substantia nigra, striatal atrophy and elevated iron levels in the basal ganglia. However, the relative contribution of these changes to the motor deficits seen in aging is unclear. Thus, using the rhesus monkey as a model, the present study was designed to examine several of these key alterations in the basal ganglia in order to help elucidate the mechanisms contributing to age-related motor decline. First, 32 female rhesus monkeys ranging from 4 to 32 years old were evaluated for their motor capabilities using an automated hand-retrieval task. Second, non-invasive MRI methods were used to estimate brain composition and to indirectly measure relative iron content in the striatum and substantia nigra. Third, in vivo microdialysis was used to evaluate basal and stimulus-evoked levels of DA and its metabolites in the striatum and substantia nigra of the same monkeys. Our results demonstrated significant decreases in motor performance, decreases in striatal DA release, and increases in striatal iron levels in rhesus monkeys as they age from young adulthood. A comprehensive statistical analysis relating age, motor performance, DA release, and iron content indicated that the best predictor of decreases in motor ability, above and beyond levels of performance that could be explained by age alone, was iron accumulation in the striatum. This suggests that striatal iron levels may be a biomarker of motor dysfunction in aging; and as such, can be monitored non-invasively by longitudinal brain MRI scans. The results also suggest that treatments aimed at reducing accumulation of excess iron in the striatum during normal aging may have beneficial effects on age-related deterioration of motor performance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442671     DOI: 10.1016/j.neurobiolaging.2005.12.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  27 in total

1.  A calorie-restricted diet decreases brain iron accumulation and preserves motor performance in old rhesus monkeys.

Authors:  Erik K Kastman; Auriel A Willette; Christopher L Coe; Barbara B Bendlin; Kris J Kosmatka; Donald G McLaren; Guofan Xu; Elisa Canu; Aaron S Field; Andrew L Alexander; Mary Lou Voytko; T Mark Beasley; Ricki J Colman; Richard H Weindruch; Sterling C Johnson
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  PKA modulates iron trafficking in the striatum via small GTPase, Rhes.

Authors:  Bo-Ran Choi; Sookhee Bang; Yong Chen; Jaime H Cheah; Sangwon F Kim
Journal:  Neuroscience       Date:  2013-08-30       Impact factor: 3.590

3.  Volume and iron content in basal ganglia and thalamus.

Authors:  Patrice Péran; Andrea Cherubini; Giacomo Luccichenti; Gisela Hagberg; Jean-François Démonet; Olivier Rascol; Pierre Celsis; Carlo Caltagirone; Gianfranco Spalletta; Umberto Sabatini
Journal:  Hum Brain Mapp       Date:  2009-08       Impact factor: 5.038

4.  Aging and physical mobility in group-housed Old World monkeys.

Authors:  Carol A Shively; Stephanie L Willard; Thomas C Register; Allyson J Bennett; Peter J Pierre; Mark L Laudenslager; Dalane W Kitzman; Martin K Childers; Robert W Grange; Stephen B Kritchevsky
Journal:  Age (Dordr)       Date:  2011-12-28

5.  Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF.

Authors:  M E Emborg; J Moirano; J Raschke; V Bondarenko; R Zufferey; S Peng; A D Ebert; V Joers; B Roitberg; J E Holden; J Koprich; J Lipton; J H Kordower; P Aebischer
Journal:  Neurobiol Dis       Date:  2009-08-04       Impact factor: 5.996

6.  Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats.

Authors:  Fang Du; Zhong-Ming Qian; Qianqian Luo; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2014-08-13       Impact factor: 5.590

7.  Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats.

Authors:  Li-Na Lu; Zhong-Ming Qian; Ka-Chun Wu; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

8.  Calculating T2 in images from a phased array receiver.

Authors:  Peter A Hardy; Anders H Andersen
Journal:  Magn Reson Med       Date:  2009-04       Impact factor: 4.668

Review 9.  Iron in chronic brain disorders: imaging and neurotherapeutic implications.

Authors:  James Stankiewicz; S Scott Panter; Mohit Neema; Ashish Arora; Courtney E Batt; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.